메뉴 건너뛰기




Volumn 19, Issue 8, 2009, Pages 1353-1357

The impact of complete surgical staging upon survival in early-stage ovarian clear cell carcinoma a multi-institutional retrospective study

(13)  Takano, Masashi a   Sugiyama, Toru b   Yaegashi, Nobuo c   Suzuki, Mitsuaki d   Tsuda, Hiroshi e   Sagae, Satoru f   Udagawa, Yasuhiro g   Kuzuya, Kazuo h   Kigawa, Junzo i   Takeuchi, Satoshi j   Tsuda, Hitoshi a   Moriya, Takuya k   Kikuchi, Yoshihiro l  


Author keywords

Clear cell carcinoma; Lymphadenectomy; Ovarian cancer; Surgical staging; Washing cytology

Indexed keywords

ADULT; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER STAGING; CANCER SURVIVAL; CLEAR CELL CARCINOMA; FEMALE; HIGH RISK POPULATION; HUMAN; HYSTERECTOMY; MAJOR CLINICAL STUDY; OVARY CARCINOMA; PARAAORTIC LYMPH NODE; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; SALPINGOOOPHORECTOMY;

EID: 73349130755     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1111/IGC.0b013e3181a83f4f     Document Type: Article
Times cited : (38)

References (35)
  • 1
    • 11844278537 scopus 로고    scopus 로고
    • Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000
    • Bray F, Loos AH, Tognazzo S, et al. Ovarian cancer in Europe: cross-sectional trends in incidence and mortality in 28 countries, 1953-2000. Int J Cancer. 2005;113:977-990.
    • (2005) Int J Cancer. , vol.113 , pp. 977-990
    • Bray, F.1    Loos, A.H.2    Tognazzo, S.3
  • 2
    • 26944473246 scopus 로고    scopus 로고
    • Annual report to the nation on the status of cancer 1975-2002, featuring population-based trends in cancer treatment
    • Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst. 2005;97:1407-1427.
    • (2005) J Natl Cancer Inst. , vol.97 , pp. 1407-1427
    • Edwards, B.K.1    Brown, M.L.2    Wingo, P.A.3
  • 3
    • 17144436447 scopus 로고    scopus 로고
    • Clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease
    • Goff BA, Sainz de la Cuesta R, Muntz HG, et al. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease. Gynecol Oncol. 1996;60:412-417.
    • (1996) Gynecol Oncol. , vol.60 , pp. 412-417
    • Goff, B.A.1    Sainz De La Cuesta, R.2    Muntz, H.G.3
  • 4
    • 0029981116 scopus 로고    scopus 로고
    • Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy
    • Recio FO, Piver MS, Hempling RE, et al. Lack of improved survival plus increase in thromboembolic complications in patients with clear cell carcinoma of the ovary treated with platinum versus nonplatinum-based chemotherapy. Cancer. 1996;78:2157-2163.
    • (1996) Cancer , vol.78 , pp. 2157-2163
    • Recio, F.O.1    Piver, M.S.2    Hempling, R.E.3
  • 5
    • 0034213974 scopus 로고    scopus 로고
    • Clinical characteristics of clear cell carcinoma of the ovary
    • Sugiyama T, Kamura T, Kigawa J, et al. Clinical characteristics of clear cell carcinoma of the ovary. Cancer. 2000;88:2584-2589.
    • (2000) Cancer , vol.88 , pp. 2584-2589
    • Sugiyama, T.1    Kamura, T.2    Kigawa, J.3
  • 6
    • 33745901335 scopus 로고    scopus 로고
    • Advanced stage clear-cell epithelial ovarian cancer: Te Hellenic Cooperative Oncology Group experience
    • Pectasides D, Fountzilas G, Aravantinos G, et al. Advanced stage clear-cell epithelial ovarian cancer: the Hellenic Cooperative Oncology Group experience. Gynecol Oncol. 2006;102:285-291.
    • (2006) Gynecol Oncol. , vol.102 , pp. 5-291
    • Pectasides, D.1    Fountzilas, G.2    Aravantinos, G.3
  • 7
    • 1942495017 scopus 로고    scopus 로고
    • Is clear cell carcinoma and mucinous carcinoma of the ovary sensitive to combination chemotherapy with paclitaxel and carboplatin?
    • Abstract 1797
    • Enomoto T, Kuragaki C, Yamasaki M, et al. Is clear cell carcinoma and mucinous carcinoma of the ovary sensitive to combination chemotherapy with paclitaxel and carboplatin? Proc Am Soc Clin Oncol. 2003;22:447. Abstract 1797.
    • (2003) Proc Am Soc Clin Oncol. , vol.22 , pp. 447
    • Enomoto, T.1    Kuragaki, C.2    Yamasaki, M.3    Al, E.4
  • 8
    • 3242725237 scopus 로고    scopus 로고
    • Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease
    • Ho CM, Huang YJ, Chen TC, et al. Pure-type clear cell carcinoma of the ovary as a distinct histological type and improved survival in patients treated with paclitaxel-platinum-based chemotherapy in pure-type advanced disease. Gynecol Oncol. 2004;94:197-203.
    • (2004) Gynecol Oncol. , vol.94 , pp. 197-203
    • Ho, C.M.1    Huang, Y.J.2    Chen, T.C.3
  • 9
    • 33646828032 scopus 로고    scopus 로고
    • Clear cell carcinoma of the ovary: A retrospective multicentre experience of 254 patients with complete surgical staging
    • Takano M, Kikuchi Y, Yaegashi N, et al. Clear cell carcinoma of the ovary: a retrospective multicentre experience of 254 patients with complete surgical staging. Br J Cancer. 2006;94:1369-1374.
    • (2006) Br J Cancer. , vol.94 , pp. 1369-1374
    • Takano, M.1    Kikuchi, Y.2    Yaegashi, N.3
  • 10
    • 0000335247 scopus 로고
    • Staging announcement
    • FIGO Cancer Committee.
    • FIGO Cancer Committee. Staging announcement. Gynecol Oncol. 1986;25:383.
    • (1986) Gynecol Oncol. , vol.25 , pp. 383
  • 11
    • 0032810988 scopus 로고    scopus 로고
    • Survival probability in ovarian clear cell adenocarcinoma
    • Kennedy AW, Markman M, Biscotti CV, et al. Survival probability in ovarian clear cell adenocarcinoma. Gynecol Oncol. 1999;74:108-114.
    • (1999) Gynecol Oncol. , vol.74 , pp. 108-114
    • Kennedy, A.W.1    Markman, M.2    Biscotti, C.V.3
  • 12
    • 0027174820 scopus 로고
    • Clear cell epithelial ovarian cancer (mesonephroid): Bad prognosis only in early stages
    • O'Brien ME, Schofield JB, Tan S, et al. Clear cell epithelial ovarian cancer (mesonephroid): bad prognosis only in early stages. Gynecol Oncol. 1993;49:250-254.
    • (1993) Gynecol Oncol. , vol.49 , pp. 250-254
    • O'brien, M.E.1    Schofield, J.B.2    Tan, S.3
  • 13
    • 0024494941 scopus 로고
    • Clear cell adenocarcinoma of the ovary: A clinical analysis and comparison with serous carcinoma
    • Jenison EL, Montag AG, Griffiths CT, et al. Clear cell adenocarcinoma of the ovary: a clinical analysis and comparison with serous carcinoma. Gynecol Oncol. 1989;32:65-71.
    • (1989) Gynecol Oncol. , vol.32 , pp. 65-71
    • Jenison, E.L.1    Montag, A.G.2    Griffiths, C.T.3
  • 14
    • 0037342761 scopus 로고    scopus 로고
    • Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage i ovarian clear cell carcinoma
    • Ho CM, Chien TY, Shih BY, et al. Evaluation of complete surgical staging with pelvic and para-aortic lymphadenectomy and paclitaxel plus carboplatin chemotherapy for improvement of survival in stage I ovarian clear cell carcinoma. Gynecol Oncol. 2003;88:394-399.
    • (2003) Gynecol Oncol. , vol.88 , pp. 394-399
    • Ho, C.M.1    Chien, T.Y.2    Shih, B.Y.3
  • 15
    • 46249099390 scopus 로고    scopus 로고
    • Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients?
    • Suzuki S, Kajiyama H, Shibata K, et al. Is there any association between retroperitoneal lymphadenectomy and survival benefit in ovarian clear cell carcinoma patients? Ann Oncol. 2008;19:1284-1287.
    • (2008) Ann Oncol. , vol.19 , pp. 1284-1287
    • Suzuki, S.1    Kajiyama, H.2    Shibata, K.3    Al, E.4
  • 16
    • 0035166671 scopus 로고    scopus 로고
    • Pattern of lymph node metastases in clinically unilateral stage i invasive epithelial ovarian carcinomas
    • Cass I, Li AJ, Runowicz CD, et al. Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas. Gynecol Oncol. 2001;80:56-61.
    • (2001) Gynecol Oncol. , vol.80 , pp. 56-61
    • Cass, I.1    Li, A.J.2    Runowicz, C.D.3
  • 17
    • 0043167991 scopus 로고    scopus 로고
    • Lymph node involvement in epithelial ovarian cancer: Analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications
    • Morice P, Joulie F, Camatte S, et al. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications. J Am Coll Surg. 2003;197:198-205.
    • (2003) J Am Coll Surg. , vol.197 , pp. 198-205
    • Morice, P.1    Joulie, F.2    Camatte, S.3
  • 18
    • 3242679931 scopus 로고    scopus 로고
    • Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer
    • Negishi H, Takeda M, Fujimoto T, et al. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer. Gynecol Oncol. 2004;94:161-166.
    • (2004) Gynecol Oncol. , vol.94 , pp. 161-166
    • Negishi, H.1    Takeda, M.2    Fujimoto, T.3
  • 19
    • 0031127765 scopus 로고    scopus 로고
    • Hirakawa T,et al. Relationship between pelvic lymph node involvement and other disease sites in patients with ovarian cancer
    • Sakai K, Kamura T, Hirakawa T,et al. Relationship between pelvic lymph node involvement and other disease sites in patients with ovarian cancer. Gynecol Oncol. 1997;65:164-168.
    • (1997) Gynecol Oncol. , vol.65 , pp. 164-168
    • Sakai, K.1    Kamura, T.2
  • 20
    • 0031832609 scopus 로고    scopus 로고
    • Early ovarian cancer: Is there a role for systematic pelvis and para-aortic lymphadenectomy?
    • Baiocchi G, Raspagliesi F, Grosso G, et al. Early ovarian cancer: is there a role for systematic pelvis and para-aortic lymphadenectomy? Int J Gynecol Cancer. 1998;8:103-108.
    • (1998) Int J Gynecol Cancer. , vol.8 , pp. 103-108
    • Baiocchi, G.1    Raspagliesi, F.2    Grosso, G.3
  • 21
    • 27144489730 scopus 로고    scopus 로고
    • Lymph node metastasis in ovarian cancer: Difference between serous and non-serous primary tumors
    • Takeshima N, Hirai Y, Umayahara K, et al. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors. Gynecol Oncol. 2005;99:427-431.
    • (2005) Gynecol Oncol. , vol.99 , pp. 427-431
    • Takeshima, N.1    Hirai, Y.2    Umayahara, K.3
  • 22
    • 0032911676 scopus 로고    scopus 로고
    • The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: Impact of nodal metastasis on patient survival
    • Kanazawa K, Suzuki T, Tokashiki M. The validity and significance of substage IIIC by node involvement in epithelial ovarian cancer: impact of nodal metastasis on patient survival. Gynecol Oncol. 1999;73: 237-241.
    • (1999) Gynecol Oncol. , vol.73 , pp. 237-241
    • Kanazawa, K.1    Suzuki, T.2    Tokashiki, M.3
  • 23
    • 0033762116 scopus 로고    scopus 로고
    • Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0)
    • Sakuragi N, Yamada H, Oikawa M, et al. Prognostic significance of lymph node metastasis and clear cell histology in ovarian carcinoma limited to the pelvis (pT1M0 and pT2M0). Gynecol Oncol. 2000; 79:251-255.
    • (2000) Gynecol Oncol. , vol.79 , pp. 251-255
    • Sakuragi, N.1    Yamada, H.2    Oikawa, M.3
  • 24
    • 33846001355 scopus 로고    scopus 로고
    • Association of lymphadenectomy and survival in stage i ovarian cancer
    • Chan JK, Munro EG, Cheung MK, et al. Association of lymphadenectomy and survival in stage I ovarian cancer. Obstet Gynecol. 2007;109:12-19.
    • (2007) Obstet Gynecol. , vol.109 , pp. 12-19
    • Chan, J.K.1    Munro, E.G.2    Cheung, M.K.3
  • 25
    • 0032531747 scopus 로고    scopus 로고
    • Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to stage I/II patients and superior survival to other stage III patients
    • Onda T, Yoshikawa H, Yasugi T, et al. Patients with ovarian carcinoma upstaged to stage III after systematic lymphadenectomy have similar survival to stage I/II patients and superior survival to other stage III patients. Cancer. 1998;83:1555-1560.
    • (1998) Cancer , vol.83 , pp. 1555-1560
    • Onda, T.1    Yoshikawa, H.2    Yasugi, T.3
  • 26
    • 33751433344 scopus 로고    scopus 로고
    • Is it justified to classify patients to stage IIIc epithelial ovarian cancer based on nodal involvement only?
    • Cliby WA, Aletti GD, Wilson TO, et al. Is it justified to classify patients to stage IIIc epithelial ovarian cancer based on nodal involvement only? Gynecol Oncol. 2006;103:797-801.
    • (2006) Gynecol Oncol. , vol.103 , pp. 797-801
    • Cliby, W.A.1    Aletti, G.D.2    Wilson, T.O.3    Al, E.4
  • 27
    • 33748571913 scopus 로고    scopus 로고
    • Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis
    • Maggioni A, Benedetti Panici P, Dell'Anna T, et al. Randomised study of systematic lymphadenectomy in patients with epithelial ovarian cancer macroscopically confined to the pelvis. Br J Cancer. 2006;95:699-704.
    • (2006) Br J Cancer. , vol.95 , pp. 699-704
    • Maggioni, A.1    Benedetti Panici, P.2    Dell'anna, T.3
  • 28
    • 0038648314 scopus 로고    scopus 로고
    • Long-term prognosis of stage i ovarian carcinoma. Prognostic importance of intraoperative rupture
    • Mizuno M, Kikkawa F, Shibata K, et al. Long-term prognosis of stage I ovarian carcinoma. Prognostic importance of intraoperative rupture. Oncology. 2003;65:29-36.
    • (2003) Oncology. , vol.65 , pp. 29-36
    • Mizuno, M.1    Kikkawa, F.2    Shibata, K.3    Al, E.4
  • 29
    • 41649093235 scopus 로고    scopus 로고
    • Prognostic factors for high-risk early-stage epithelial ovarian cancer: A Gynecologic Oncology Group study
    • Chan JK, Tian C, Monk BJ, et al. Prognostic factors for high-risk early-stage epithelial ovarian cancer: a Gynecologic Oncology Group study. Cancer. 2008;112:2202-2210.
    • (2008) Cancer , vol.112 , pp. 2202-2210
    • Chan, J.K.1    Tian, C.2    Monk, B.J.3
  • 30
    • 0344413004 scopus 로고    scopus 로고
    • Expression profiling in ovarian clear cell carcinoma: Identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma
    • Tsuchiya A, Sakamoto M, Yasuda J, et al. Expression profiling in ovarian clear cell carcinoma: identification of hepatocyte nuclear factor-1 beta as a molecular marker and a possible molecular target for therapy of ovarian clear cell carcinoma. Am J Pathol. 2003;163:2503-2512.
    • (2003) Am J Pathol. , vol.163 , pp. 2503-2512
    • Tsuchiya, A.1    Sakamoto, M.2    Yasuda, J.3
  • 31
    • 32844470073 scopus 로고    scopus 로고
    • Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary
    • Kato N, Sasou S, Motoyama T. Expression of hepatocyte nuclear factor-1beta (HNF-1beta) in clear cell tumors and endometriosis of the ovary. Mod Pathol. 2006;19:83-89.
    • (2006) Mod Pathol. , vol.19 , pp. 83-89
    • Kato, N.1    Sasou, S.2    Motoyama, T.3
  • 32
    • 27244438465 scopus 로고    scopus 로고
    • WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma
    • Kaneuchi M, Sasaki M, Tanaka Y, et al. WT1 and WT1-AS genes are inactivated by promoter methylation in ovarian clear cell adenocarcinoma. Cancer. 2005;104:1924-1930.
    • (2005) Cancer , vol.104 , pp. 1924-1930
    • Kaneuchi, M.1    Sasaki, M.2    Tanaka, Y.3
  • 33
    • 26444492637 scopus 로고    scopus 로고
    • Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinoma by cDNA microarray analysis
    • Tsuda H, Ito YM, Ohashi Y, et al. Identification of overexpression and amplification of ABCF2 in clear cell ovarian adenocarcinoma by cDNA microarray analysis. Clin Cancer Res. 2005;11:6880-6888.
    • (2005) Clin Cancer Res. , vol.11 , pp. 6880-6888
    • Tsuda, H.1    Ito, Y.M.2    Ohashi, Y.3
  • 34
    • 0026505916 scopus 로고
    • Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies
    • Panici PB, Scambia G, Baiocchi G, et al. Anatomical study of para-aortic and pelvic lymph nodes in gynecologic malignancies. Obstet Gynecol. 1992;79:498-502.
    • (1992) Obstet Gynecol. , vol.79 , pp. 498-502
    • Panici, P.B.1    Scambia, G.2    Baiocchi, G.3
  • 35
    • 34248341789 scopus 로고    scopus 로고
    • Pelvic and aortic lymph node metastasis in epithelial ovarian cancer
    • Pereira A, Magrina JF, Victoria R, et al. Pelvic and aortic lymph node metastasis in epithelial ovarian cancer. Gynecol Oncol. 2007;105:604-608.
    • (2007) Gynecol Oncol. , vol.105 , pp. 604-608
    • Pereira, A.1    Magrina, J.F.2    Victoria, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.